Douglas Grossman Selected Research

Douglas Grossman Research Topics

Disease

36	Melanoma (Melanoma, Malignant) 12/2023 - 01/2003
22	Neoplasms (Cancer) 01/2022 - 02/2003
9	Pigmented Nevus (Melanocytic Nevus) 01/2022 - 01/2005
9	Nevus (Nevi) 01/2022 - 01/2005
5	Neoplasm Metastasis (Metastasis) 09/2013 - 06/2007
4	Carcinogenesis 01/2023 - 02/2003
4	Skin Neoplasms (Skin Cancer) 01/2021 - 02/2003
3	Sunburn 01/2023 - 01/2021
2	Inflammation (Inflammations) 01/2023 - 01/2021
2	COVID-19 01/2022 - 01/2021
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 02/2003
2	Carcinoma (Carcinomatosis) 01/2019 - 02/2003
2	Cutaneous Malignant Melanoma 04/2013 - 03/2006
1	Basal Cell Carcinoma (Rodent Ulcer) 01/2022
1	Nevi and Melanomas 11/2021
1	Immune System Diseases (Immune Disorders) 06/2021
1	Tuberculosis (Tuberculoses) 06/2021
1	Brain Neoplasms (Brain Tumor) 01/2017
1	Retinoblastoma (Glioblastoma, Retinal) 01/2008
1	Hyperplasia 06/2004
1	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2004
1	Neurodermatitis (Lichen Simplex Chronicus) 06/2004

Drug/Important Bio-Agent (IBA)

13	SurvivinIBA 09/2013 - 01/2003
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 06/2014
4	Melanins (Melanin)IBA 01/2023 - 01/2013
4	AntioxidantsIBA 01/2023 - 10/2007
4	8-hydroxyguanineIBA 01/2023 - 01/2017
4	Dinoprostone (PGE2)FDA Link 01/2022 - 10/2018
3	Pyrimidine DimersIBA 01/2023 - 01/2021
3	tributyl phosphate (TBP)IBA 04/2020 - 09/2006
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 08/2017 - 01/2004
3	Acetylcysteine (Siran)FDA LinkGeneric 01/2017 - 10/2007
3	CaspasesIBA 10/2006 - 01/2004
2	AntibodiesIBA 01/2023 - 06/2021
2	Sunscreening Agents (Sunscreens)IBA 01/2021 - 01/2018
2	Adenosine Monophosphate (AMP)IBA 01/2020 - 01/2019
2	CytokinesIBA 01/2020 - 01/2004
2	Type 1 Melanocortin ReceptorIBA 01/2020 - 03/2006
2	IntegrinsIBA 09/2013 - 10/2010
2	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2013 - 12/2009
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 10/2007 - 09/2007
2	Cisplatin (Platino)FDA LinkGeneric 09/2006 - 01/2003
1	Free Radical ScavengersIBA 01/2023
1	MicroRNAs (MicroRNA)IBA 11/2021
1	Immunologic Factors (Immunomodulators)IBA 06/2021
1	VaccinesIBA 06/2021
1	Immune Checkpoint InhibitorsIBA 06/2021
1	Vitamin D FDA LinkGeneric 06/2020
1	salicylurate (salicyluric acid)IBA 01/2020
1	SalicylatesIBA 01/2020
1	2,5-dihydroxybenzoic acid (gentisic acid)IBA 01/2020
1	Protein Kinases (Protein Kinase)IBA 01/2020
1	Anticarcinogenic AgentsIBA 01/2020
1	Celecoxib (Celebrex)FDA Link 10/2018
1	Adenylate KinaseIBA 10/2018
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 10/2018
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2017
1	tyrosine receptor (receptor, tyrosine)IBA 12/2017
1	Phosphotransferases (Kinase)IBA 12/2017
1	ThioredoxinsIBA 01/2017
1	Interleukin-2 (IL2)IBA 09/2016
1	IpilimumabIBA 09/2016
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 06/2014
1	PlasticsIBA 09/2013
1	Fibronectins (Fibronectin)IBA 09/2013
1	AgarIBA 09/2013
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 04/2013
1	Cyclin-Dependent Kinase Inhibitor p16IBA 04/2013
1	SeleniumIBA 03/2013
1	methylselenic acidIBA 03/2013
1	Selenomethionine (Sethotope)FDA Link 03/2013
1	Integrin alpha5beta1IBA 10/2010
1	Integrin alpha5IBA 10/2010
1	Glutathione (Reduced Glutathione)IBA 12/2009
1	Cysteine (L-Cysteine)FDA Link 12/2009
1	naamidine AIBA 07/2009
1	Caspase 3 (Caspase-3)IBA 07/2009
1	AlkaloidsIBA 07/2009
1	Antineoplastic Agents (Antineoplastics)IBA 07/2009
1	Formaldehyde (Formol)FDA Link 11/2008
1	ParaffinIBA 11/2008
1	Inhibitor of Apoptosis ProteinsIBA 01/2008
1	Sulfhydryl Compounds (Thiols)IBA 10/2007
1	beta-Galactosidase (Lactaid)IBA 10/2007
1	Drinking WaterIBA 10/2007
1	9,10-Dimethyl-1,2-benzanthraceneIBA 06/2007
1	Protease Inhibitors (Protease Inhibitor)IBA 09/2006
1	High-Temperature Requirement A Serine Peptidase 2IBA 09/2006
1	Cyclin-Dependent Kinase 4IBA 03/2006
1	Imatinib Mesylate (Gleevec)FDA Link 12/2004

Therapy/Procedure

7	Therapeutics 12/2023 - 05/2009
6	Chemoprevention 01/2020 - 12/2009
2	Immunotherapy 12/2023 - 06/2021
2	Oral Administration 01/2017 - 03/2013
1	Electrodes (Electrode) 01/2022
1	Continuity of Patient Care 01/2022
1	Cell Transplantation 01/2017
1	Transplantation 01/2017
1	Intraperitoneal Injections 09/2013